Creative Biolabs presents lower esophageal sphincter motility assay services, streamlining the comprehensive assessment and identification of anomalous patterns and physiological mechanisms within the LES. Through these cutting-edge services, a diverse array of information can be acquired to help the drug development process.
Lower esophageal sphincter (LES), located at the distal end of the esophagus, plays a crucial role as a "live valve" to prevent the backflow of gastric contents into the esophagus.
Fig.1 Structural characteristics of the LES.1
|
|
The esophagram represents a radiographic exploration of the esophagus, entailing the patient's ingestion of barium (a contrast agent) and subsequent visualization of the esophagus and stomach using fluoroscopy techniques. Application:
|
Upper endoscopy is a diagnostic procedure enabling direct visualization of the esophageal, stomach, and upper small intestine (duodenum) linings using an endoscope passed through the oral cavity. Application:
|
|
|
Esophageal manometry entails the insertion of a narrow tube through the nasal passage into the esophagus. The measurement of esophageal function is achieved by recording the pressure readings of esophageal muscle motility. Application:
|
The procedure involves the insertion of a slender tube through the nasal passage into the esophagus, positioned at the level of the LES. Equipped with a pH sensor at its tip, this tube enables the collection of acid exposure measurements within the esophagus, which are recorded on a portable computer. The pH probe is worn continuously for a duration of 24 hours. Application:
|
The LES functions as the paramount component of the anti-reflux barrier at the esophagogastric junction. Abnormal LES pressure can lead to various motility disorders.
GERD is a prominent disorder of the upper gastrointestinal tract, is characterized by acid reflux, heartburn, intractable cough, and asthma resulting from the regurgitation of upper gastrointestinal contents into the esophagus.
Characterized by impaired peristaltic motility (with diminished propulsive contractions), the LES fails to fully relax, resulting in food
passage obstruction and esophageal dilation.
Achalasia manifests as a progressive development of dysphagia and regurgitation whose neurogenic etiology is characterized by three aberrant esophageal motility findings—absence of peristalsis, elevated resting pressure of the LES, and compromised receptive relaxation of the LES.
Fig.2 Disruption of the anti-reflux barrier at the esophageal junction.1
Creative Biolabs has meticulously curated a comprehensive repertoire of platforms aimed at assessing the effects of drugs on the LES. Our platform embraces a diverse spectrum of LES motility assay approaches and a wide range of 3D biology-based models, rendering invaluable support to our esteemed clientele. Our high-quality models encompass a wide range, including but not limited to:
If you have any related inquiries, please feel free to contact us for further information.
Reference